Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05113381 · ClinicalTrials.gov registry record · NA
The Purpose of This Study is to Determine Whether CerebroFlo™ EVD Catheter is Effective During the Treatment of Intraventricular Hemorrhage (IVH)
A NA study, sponsored by Integra LifeSciences Corporation.
- Completed
- Registry status
- NA
- Development phase
- 105
- Enrollment target
NCT05113381 is a NA study that has completed, run by Integra LifeSciences Corporation. The registered enrollment target is 105 participants.
The verdict
NCT05113381, a NA study, has completed, sponsored by Integra LifeSciences Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
Study Summary
The primary goal of this study is to assess the occurrence of flushing interventions to address occlusions during the treatment of interventricular hemorrhage (spontaneous primary IVH or secondary IVH due to ruptured aneurysm).
Interventions
- DEVICE CerebroFlo™ EVD Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2021-09-15 |
| Est. Completion | 2025-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05113381
The ClinicalTrials.gov registry entry for NCT05113381 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CerebroFlo™ EVD Catheter is the first listed.
NCT05113381 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05113381 about?
NCT05113381 is a clinical study titled "The Purpose of This Study is to Determine Whether CerebroFlo™ EVD Catheter is Effective During the Treatment of Intraventricular Hemorrhage (IVH)". The primary goal of this study is to assess the occurrence of flushing interventions to address occlusions during the treatment of interventricular hemorrhage (spontaneous primary IVH or secondary IVH due to ruptured aneurysm).
What is the current status of trial NCT05113381?
This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2021-09-15. Estimated completion is 2025-07-31.
What interventions are being tested in trial NCT05113381?
The interventions under investigation include: CerebroFlo™ EVD Catheter (DEVICE).
Who is sponsoring clinical trial NCT05113381?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.